search
Back to results

Intervention With Cerebral Embolic Protection in TEVAR: Gaseous Protection (INTERCEPT:GP)

Primary Purpose

Stroke, Silent Cerebral Infarction, Neurocognitive Dysfunction

Status
Recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
CO2 flushing
Saline flushing
Sponsored by
Imperial College London
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Stroke focused on measuring Stroke, Silent cerebral infarction, Carbon dioxide, Thoracic endovascular aortic repair, TEVAR, DW-MRI, Vascular brain infarction

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • All participants suitable for TEVAR with capacity to consent

Exclusion Criteria:

  • Participants who lack capacity to consent
  • Contraindications to MRI such as pacemaker
  • Pregnant participants
  • Participants who do not wish to participate
  • Participants <18yrs

Sites / Locations

  • Imperial College LondonRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

carbon-dioxide

Saline

Arm Description

Flushing of stent-grafts in TEVAR with carbon-dioxide

Flushing of stent-grafts with saline

Outcomes

Primary Outcome Measures

Recruitment
The number of patients recruited into the trial will be collected
Retention
The proportion of patients undergoing follow-up assessments will be collected
Study design for full randomised controlled trial
The proportion of patients who are eligible for the trial will be collected

Secondary Outcome Measures

Number, size and location of new ischaemic lesions on post-operative diffusion-weighted MRI scans
Using DW-MRI at <72 hours post operatively (day 1-7), and also 6 months post operatively, we will assess for new ischaemic lesions
Number of gaseous and solid intra-operative transcranial doppler microembolic signals by phase of TEVAR
At all London units, transcranial doppler insonation of the middle cerebral artery will be carried out during the procedure, and analysed offline at a later date to evaluate gaseous or solid emboli during TEVAR
Number of participants with stroke or delirium as an inpatient
Patients will undergo stroke and delirium assessment.
Serial biomarker blood tests
Blood samples will be taken preoperatively, at the end of the procedure and 24 hours late. These will be analysed for a biomarker of neuroglial injury, S100B
Risk factor assessment
Data such as stent type will be collected.
Neurological assessment, delirium assessment and quality of life testing
Patients will undergo a baseline neurocognitive, delirium and quality of life testing. These will be repeated as an outpatient to measure change post operatively.

Full Information

First Posted
March 20, 2019
Last Updated
October 19, 2023
Sponsor
Imperial College London
Collaborators
Imperial College Healthcare NHS Trust, Guy's and St Thomas' NHS Foundation Trust, St George's University Hospitals NHS Foundation Trust, University Hospitals Coventry and Warwickshire NHS Trust, South Canterbury DHB, New Zealand, Baylor Scott and White Health, University Hospital Southampton NHS Foundation Trust, Health New Zealand
search

1. Study Identification

Unique Protocol Identification Number
NCT03886675
Brief Title
Intervention With Cerebral Embolic Protection in TEVAR: Gaseous Protection
Acronym
INTERCEPT:GP
Official Title
Carbon-Dioxide Flushing Versus Saline Flushing in Thoracic Endovascular Aortic Repair to Reduce Neurological Injury: A Pilot Randomised Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 14, 2022 (Actual)
Primary Completion Date
June 6, 2024 (Anticipated)
Study Completion Date
October 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Imperial College London
Collaborators
Imperial College Healthcare NHS Trust, Guy's and St Thomas' NHS Foundation Trust, St George's University Hospitals NHS Foundation Trust, University Hospitals Coventry and Warwickshire NHS Trust, South Canterbury DHB, New Zealand, Baylor Scott and White Health, University Hospital Southampton NHS Foundation Trust, Health New Zealand

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Vascular brain infarction (VBI) occurs in 67% of patients undergoing TEVAR. Overt stroke occurs in 13% of these patients and 88% of patients suffer from neurocognitive impairment. Cerebral air embolisation during the stent-graft deployment phase of TEVAR may be a cause of VBI. Standard treatment to de-air stent-grafts is through the use of a saline flush. This study aims to investigate whether carbon-dioxide or saline is the better fluid to de-air TEVAR stent-grafts prior to insertion in to the patient and compare VBI rate in the carbon-dioxide group and saline group.
Detailed Description
Thoracic endovascular aortic repair (TEVAR) is the re-lining of the thoracic aorta to prevent life threatening haemorrhage and death from rupture. This involves a small cut in the femoral artery in the groin and under imaging guidance, the insertion of wires and a stent into the thoracic aorta. Prior to insertion into the patient, stents are flushed with saline to remove air and prevent air reaching the brain that can cause a form of brain injury known as vascular brain infarction (VBI). However, our preliminary clinical data suggests that saline flushing is not effective at de-airing stent-grafts used in TEVAR. Carbon-dioxide has been used extensively in cardiac surgery to displace air from the chest cavity to prevent peri-procedural cerebral air embolisation. We hypothesise that flushing the stent-grafts with carbon-dioxide may be better at removing air from the stent-grafts than saline flush. Patients undergoing TEVAR will be approached to participate in this study. After written consent is obtained, participants will be randomised to undergo (TEVAR) with carbon dioxide or saline flushing of stent-grafts. Pre-operatively, participants will undergo extensive neurocognitive testing, and a baseline blood test. Intra-operatively, participants will undergo continuous transcranial doppler monitoring (TCD) of the middle cerebral artery (MCA) to look for cerebral air embolisation at stent-graft deployment phase of TEVAR. Blood testing pre-op, immediately post op, and 24 hours post op will be taken to measure for biomarkers of brain injury. Post-operatively, participants will undergo another diffusion-weighted brain MRI within 72 hours post-procedure, stroke and delirium assessment at day 1, 3 and day 7 +/- day of discharge, and at 6-weeks and 6-month follow-up.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke, Silent Cerebral Infarction, Neurocognitive Dysfunction, Vascular Brain Injury
Keywords
Stroke, Silent cerebral infarction, Carbon dioxide, Thoracic endovascular aortic repair, TEVAR, DW-MRI, Vascular brain infarction

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
1:1 randomisation
Masking
ParticipantOutcomes Assessor
Masking Description
Participants will be blinded to treatment allocation. Assessment of TCD embolic data, DW-MRI scan reporting and neurological and neurocognitive assessment will be carried out by blinded trained assessors.
Allocation
Randomized
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
carbon-dioxide
Arm Type
Experimental
Arm Description
Flushing of stent-grafts in TEVAR with carbon-dioxide
Arm Title
Saline
Arm Type
Active Comparator
Arm Description
Flushing of stent-grafts with saline
Intervention Type
Other
Intervention Name(s)
CO2 flushing
Intervention Description
As above
Intervention Type
Other
Intervention Name(s)
Saline flushing
Intervention Description
As above
Primary Outcome Measure Information:
Title
Recruitment
Description
The number of patients recruited into the trial will be collected
Time Frame
36 months
Title
Retention
Description
The proportion of patients undergoing follow-up assessments will be collected
Time Frame
36 months
Title
Study design for full randomised controlled trial
Description
The proportion of patients who are eligible for the trial will be collected
Time Frame
36 months
Secondary Outcome Measure Information:
Title
Number, size and location of new ischaemic lesions on post-operative diffusion-weighted MRI scans
Description
Using DW-MRI at <72 hours post operatively (day 1-7), and also 6 months post operatively, we will assess for new ischaemic lesions
Time Frame
36 months
Title
Number of gaseous and solid intra-operative transcranial doppler microembolic signals by phase of TEVAR
Description
At all London units, transcranial doppler insonation of the middle cerebral artery will be carried out during the procedure, and analysed offline at a later date to evaluate gaseous or solid emboli during TEVAR
Time Frame
Duration of surgery, 36 months collection
Title
Number of participants with stroke or delirium as an inpatient
Description
Patients will undergo stroke and delirium assessment.
Time Frame
These will be carried out within 48 hours of patients' return to level 1 care. 36 months collection
Title
Serial biomarker blood tests
Description
Blood samples will be taken preoperatively, at the end of the procedure and 24 hours late. These will be analysed for a biomarker of neuroglial injury, S100B
Time Frame
36 months
Title
Risk factor assessment
Description
Data such as stent type will be collected.
Time Frame
36 months
Title
Neurological assessment, delirium assessment and quality of life testing
Description
Patients will undergo a baseline neurocognitive, delirium and quality of life testing. These will be repeated as an outpatient to measure change post operatively.
Time Frame
Pre-op, first outpatient assessment (approximately 6 weeks), 6 months. 36 months collection

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: All participants suitable for TEVAR with capacity to consent Exclusion Criteria: Participants who lack capacity to consent Contraindications to MRI such as pacemaker Pregnant participants Participants who do not wish to participate Participants <18yrs
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lydia Hanna
Phone
07747002704
Email
l.hanna@imperial.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Richard Gibbs
Email
r.gibbs@nhs.net
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Richard Gibbs
Organizational Affiliation
Imperial College London
Official's Role
Principal Investigator
Facility Information:
Facility Name
Imperial College London
City
London
ZIP/Postal Code
W2 1NY
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ruth Nicholson
Email
r.nicholson@imperial.ac.uk

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Data requests can be made to the corresponding author and make on a case by case basis
IPD Sharing Time Frame
10 years
IPD Sharing Access Criteria
These will be reviewed on a case by case basis
Citations:
PubMed Identifier
29431856
Citation
Perera AH, Rudarakanchana N, Monzon L, Bicknell CD, Modarai B, Kirmi O, Athanasiou T, Hamady M, Gibbs RG. Cerebral embolization, silent cerebral infarction and neurocognitive decline after thoracic endovascular aortic repair. Br J Surg. 2018 Mar;105(4):366-378. doi: 10.1002/bjs.10718. Epub 2018 Feb 12.
Results Reference
background
PubMed Identifier
24841546
Citation
Kahlert P, Eggebrecht H, Janosi RA, Hildebrandt HA, Plicht B, Tsagakis K, Moenninghoff C, Nensa F, Mummel P, Heusch G, Jakob HG, Forsting M, Erbel R, Schlamann M. Silent cerebral ischemia after thoracic endovascular aortic repair: a neuroimaging study. Ann Thorac Surg. 2014 Jul;98(1):53-8. doi: 10.1016/j.athoracsur.2014.03.037. Epub 2014 May 17.
Results Reference
background
PubMed Identifier
30629169
Citation
Masada K, Kuratani T, Shimamura K, Kin K, Shijo T, Goto T, Sawa Y. Silent cerebral infarction after thoracic endovascular aortic repair: a magnetic resonance imaging study. Eur J Cardiothorac Surg. 2019 Jun 1;55(6):1071-1078. doi: 10.1093/ejcts/ezy449.
Results Reference
background
PubMed Identifier
27994872
Citation
Inci K, Koutouzi G, Chernoray V, Jeppsson A, Nilsson H, Falkenberg M. Air bubbles are released by thoracic endograft deployment: An in vitro experimental study. SAGE Open Med. 2016 Dec 7;4:2050312116682130. doi: 10.1177/2050312116682130. eCollection 2016.
Results Reference
background
PubMed Identifier
27798380
Citation
Rohlffs F, Tsilimparis N, Saleptsis V, Diener H, Debus ES, Kolbel T. Air Embolism During TEVAR: Carbon Dioxide Flushing Decreases the Amount of Gas Released from Thoracic Stent-Grafts During Deployment. J Endovasc Ther. 2017 Feb;24(1):84-88. doi: 10.1177/1526602816675621. Epub 2016 Oct 26.
Results Reference
background
PubMed Identifier
18222261
Citation
Martens S, Neumann K, Sodemann C, Deschka H, Wimmer-Greinecker G, Moritz A. Carbon dioxide field flooding reduces neurologic impairment after open heart surgery. Ann Thorac Surg. 2008 Feb;85(2):543-7. doi: 10.1016/j.athoracsur.2007.08.047.
Results Reference
background
PubMed Identifier
25939908
Citation
Ganguly G, Dixit V, Patrikar S, Venkatraman R, Gorthi SP, Tiwari N. Carbon dioxide insufflation and neurocognitive outcome of open heart surgery. Asian Cardiovasc Thorac Ann. 2015 Sep;23(7):774-80. doi: 10.1177/0218492315583562. Epub 2015 May 4.
Results Reference
background
PubMed Identifier
21371850
Citation
Bismuth J, Garami Z, Anaya-Ayala JE, Naoum JJ, El Sayed HF, Peden EK, Lumsden AB, Davies MG. Transcranial Doppler findings during thoracic endovascular aortic repair. J Vasc Surg. 2011 Aug;54(2):364-9. doi: 10.1016/j.jvs.2010.12.063. Epub 2011 Mar 3.
Results Reference
background

Learn more about this trial

Intervention With Cerebral Embolic Protection in TEVAR: Gaseous Protection

We'll reach out to this number within 24 hrs